CNR Institutional Research Information System

PISANO, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.568
NA - Nord America 1.284
EU - Europa 845
SA - Sud America 367
AF - Africa 35
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.218
SG - Singapore 1.005
CN - Cina 601
IT - Italia 383
BR - Brasile 306
HK - Hong Kong 263
VN - Vietnam 212
FR - Francia 117
BD - Bangladesh 116
KR - Corea 112
NL - Olanda 103
JP - Giappone 94
DE - Germania 51
IN - India 48
GB - Regno Unito 40
FI - Finlandia 34
CA - Canada 33
AT - Austria 31
AR - Argentina 27
IL - Israele 21
MX - Messico 21
ZA - Sudafrica 16
ID - Indonesia 15
PL - Polonia 13
IQ - Iraq 12
ES - Italia 11
IE - Irlanda 11
TR - Turchia 11
UA - Ucraina 8
UZ - Uzbekistan 8
EC - Ecuador 7
PK - Pakistan 7
SA - Arabia Saudita 7
CO - Colombia 6
CZ - Repubblica Ceca 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
PH - Filippine 5
PY - Paraguay 5
RU - Federazione Russa 5
VE - Venezuela 5
AU - Australia 4
CL - Cile 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
AL - Albania 3
BE - Belgio 3
CH - Svizzera 3
MY - Malesia 3
TN - Tunisia 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CU - Cuba 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MZ - Mozambico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.106
Salva come PNG Salva come JPEG
Città #
Singapore 588
Santa Clara 306
Hong Kong 260
Hefei 247
San Jose 168
Ashburn 121
Seoul 108
Lauterbourg 100
Beijing 92
Ho Chi Minh City 78
Tokyo 74
Los Angeles 66
Hanoi 55
Dallas 50
Milan 39
São Paulo 34
New York 32
Cavallino 28
Boardman 26
Amsterdam 25
Vienna 25
Guangzhou 24
Rome 23
Buffalo 22
San Gregorio di Catania 21
Cagliari 20
Genoa 19
Frankfurt am Main 18
Helsinki 18
Bari 17
Minamishinagawa 15
Council Bluffs 14
Sassari 13
Bengaluru 12
Naples 12
Rio de Janeiro 12
Sala Baganza 12
Dublin 11
Düsseldorf 11
Turku 11
Assemini 10
Orem 10
Warsaw 10
Denver 9
Brooklyn 8
Da Nang 8
Florence 8
Houston 8
Hải Dương 8
Jakarta 8
Johannesburg 8
Manchester 8
Mexico City 8
Montreal 8
Munich 8
Phoenix 8
Chennai 7
London 7
Porto Alegre 7
Tashkent 7
Toronto 7
Chicago 6
Las Vegas 6
Mumbai 6
Baghdad 5
Biên Hòa 5
Brasília 5
Buenos Aires 5
Elk Grove Village 5
Haiphong 5
Hortolândia 5
Istanbul 5
Lappeenranta 5
Madrid 5
Salvador 5
San Francisco 5
Atlanta 4
Belo Horizonte 4
Boston 4
Charlotte 4
Curitiba 4
Guayaquil 4
Kingston 4
Nairobi 4
Newark 4
Ninh Bình 4
Perugia 4
Prague 4
Soleminis 4
Stockholm 4
Sumaré 4
Afragola 3
Ankara 3
Asunción 3
Baltimore 3
Betim 3
Casablanca 3
Catania 3
Dhaka 3
Falkenstein 3
Totale 3.162
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 121
Inhibitory Effect of Curcumin-Inspired Derivatives on Tyrosinase Activity and Melanogenesis 108
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 94
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 87
Antitumoral effects of Vanadium compounds in malignant melanoma cell lines 87
ANTIPROLIFERATIVE ACTIVITY OF VANADIUM COMPOUNDS: EFFECTS ON THE MAJOR MALIGNANT MELANOMA MOLECULAR PATHWAYS 84
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 81
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 80
Antioxidant, Antimicrobial, and Other Biological Properties of Pompia Juice 79
Synthesis of Hydroxylated Biphenyls Derivatives Bearing an Alpha, Beta-Unsaturated Ketone as Lead Structure for the Development of New Drug Candidates Against Malignant Melanoma 78
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 77
Il CSCC: aspetti distintivi della patologia 77
Michael Acceptor Bearing A Hydroxylated Biphenyl Structure As Molecular Core For New Compounds Against Malignant Melanoma Cells 76
Germline and somatic NGS-based analysis on BRCA-related tumors 76
Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report 73
Attività anti-proliferativa e pro-apoptotica di bifenili derivati dall eugenolo e dall isoeugenolo su cellule tumorali di melanoma maligno. 72
Anticancer activity of two novel hydroxylated biphenyl compounds toward malignant melanoma cells 69
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 69
Liquid biopsy in clinical oncology 66
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 65
Molecular Basis of open-angle glaucoma in Italy 64
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 64
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 64
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 64
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 62
Molecular landscape profile of melanoma 62
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Analoghi strutturali della curcumina come potenziali agenti antitumorali contro il melanoma maligno. 59
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 57
In vitro and in vivo evaluation of the antitumour activity for a new curcumin-related compound in melanoma and neuroblastoma cells 55
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 53
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 52
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 52
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 52
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 51
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 50
Antiproliferative activity of eugenol and curcumin related biphenyls on malignant melanoma cell lines 48
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 48
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 47
"Proprietà Funzionali e Possibile Valorizzazione delle Foglie di Vitigni Endemici" 47
PROTEOMIC PROFILE MODIFICATIONS INDUCED IN MALIGNANT MELANOMA CELLS BY THE CURCUMIN ANALOGUE COMPOUND D6 47
Polimorfismi del sistema renina-angiotensina in una popolazione del Nord Sardegna: associazione fra angiotensinogeno ed ipertensione arteriosa essenziale ad insorgenza precoce. 46
Preparation of new hydroxylated natural-like biphenyls and their antitumoral activity. 44
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 44
Functionalization of Hydroxylated Phenols and Biphenols Bearing an a,b-Unsaturated Keton as Lead Compound 44
Caratterizzazione dei meccanismi d'azione coinvolti nell'attività antitumorale di composti del vanadio su cellule di melanoma maligno 42
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 41
Proteomic analysis in melanoma cell lines with different genotypes 40
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 40
Molecular changes induced by the curcumin biphenyl analogue D6 in melanoma cells 38
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling 38
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 38
DISSECTING MOLECULAR PATHWAYS INVOLVED IN THE ANTIPROLIFERATIVE EFFECTS OF VANADIUM COMPOUNDS IN A375 MALIGNANT MELANOMA CELL LINE. 37
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. 36
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 36
Mechanism of pathogenicity in Salmonella abortusovis 36
"Genomic instability of the human chromosome 10q25-q26 in patients with endometrial cancer". In New technologies for gynecologic and obstetric investigation. 4th Congress of the European society for gynecologic and obstetric investigation (1999) 36
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 35
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 35
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 34
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 34
A refined physical and EST map spanning 7.4 Mb of 10q24, a region involved in neurological disorders 34
Identification of a founder BRCA2 mutation in Sardinia 33
L'istituto di Chimica Biomolecolare a Sassari, Parte seconda 32
Molecular basis of open-angle glaucoma in Italy 32
In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells. 32
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 31
The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB 31
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 30
Cloning, expression, and function of TFC5, the gene encoding the B'' component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB 30
Microsatellite Analysis at 10q25-q26 in Sardinian Patients with Sporadic Endometrial Carcinoma:Identification of Specific Patterns of Genetic Alteration 29
2,2-dihydroxy-3,3-dimethoxy-5,5-dimethyl-6,6-dibromo-1,1-biphenyl: preparation, resolution, structure and biological activity. 29
Caratterizzazione dei Meccanismi Molecolari Alla Base dell Attivita Antitumorale dell Analogo Struttuale della Curcumina D6. 28
"Transcription by RNA polimerase III" In Transcription: Mechanism and Regulation 28
Studio Biologico Cellulare e Molecolare di Nuovi Composti Bioattivi nel Melanoma Maligno 27
4-Substituted-2-Methoxyphenol: Suitable Building Block to Prepare New Bioactive Natural-like Hydroxylated Biphenyls 27
ASSESSMENT OF THE IN VITRO ACTIVITY OF RGDECHI-HCIT, alpha V beta3 INTEGRIN ANTAGONIST, ON MALIGNANT MELANOMA CELLS 26
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 26
New curcumin analogues as potential antitumour agents against malignant melanoma. 26
Natural derived hydroxylated byphenyl compounds as potential anti-melanoma agents. 26
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 25
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 25
How to treat BRAF mutant metastatic melanoma? 25
Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6 24
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 24
Preparazione, Risoluzione, Struttura ed Attività Citotossica di un Equivalente Bromurato del Deidrodicreosolo 24
La chimica biomolecolare entra nelle scuole per svelare misteri e diffondere conoscenze 24
Gene Expression Profile of Malignant Melanoma Cells Treated with a Structural Analogue of Curcumin (D6) 24
Preparation of new hydroxylated Natural-like Biphenyls and their Antitumoral Activity Against Malignant Melanoma 23
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 23
Antiproliferative and pro-apoptotic activity of eugenol related biphenyls on malignant melanoma tumour cell lines 23
Sviluppo di Bifenili Idrossilati analoghi della curcumina come agenti antitumorali contro il MElanoma maligno - BICOME 23
Totale 4.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.922
article - articoli 10.903
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 697
Totale 28.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202479 0 0 0 0 0 0 0 0 4 2 51 22
2024/20251.849 21 5 105 80 321 104 58 114 79 110 467 385
2025/20263.226 190 272 282 389 547 153 445 222 206 205 170 145
2026/202793 93 0 0 0 0 0 0 0 0 0 0 0
Totale 5.247